British diagnostics technology developer Creavo Medical has obtained CE mark to launch its first device, Vitalscan in Europe.

Creavo’s Vitalscan is a battery powered and portable medical device that can be used in a routine and acute hospital setting while retaining accuracy and efficacy of the older technology SQUID devices.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Using advanced quantum principles, the device measures, displays and stores electromagnetic fluctuations caused by heart activity through a simple, non-invasive three to five-minute scan at a patient’s bedside.

"There is compelling early evidence that Magnetocardiography (MCG) as utilised in Vitalscan, can quickly and accurately rule out suspected heart attack in emergency chest pain patients."

This scan accurately and quickly rules out significant ischaemic heart disease, such as heart attacks.

The 3-5 minute RULE OUT test gives results on site with very high Negative Predictive Value aiding the healthcare professionals for the chest pain triage process without having to wait for inconclusive lab results.

See Also:

Creavo Medical Technologies’ Medical Advisory Board chairperson Dr Richard Charles said: “There is compelling early evidence that Magnetocardiography (MCG) as utilised in Vitalscan, can quickly and accurately rule out suspected heart attack in emergency chest pain patients, rapidly relieving both patient anxiety and health care costs.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“The development of Vitalscan opens an exciting new chapter in understanding and managing heart disease.”

The company will now conduct a largescale, multi-centre clinical trial of the device at four major UK sites.

Previously held small sets of demonstrated efficacy of Vitalscan to improve the current triage process for patients admitted to emergency departments with chest pain.